Business Context and Reporting Period
This Form 8-K Current Report was filed by E. I. du Pont de Nemours and Company (DuPont) on October 6, 2009. The filing discloses a forward-looking statement made by Executive Vice President Mark P. Vergnano during an investor meeting held on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on management's qualitative outlook regarding future profitability.
Material Changes and Outlook
Management provided a specific timeline for the company's financial recovery:
- Return to Profitability: Mr. Vergnano stated an expectation that it would take approximately two and one-half to three years for the company to return to its 2008 profitability levels.
- Segment Impact: This timeline explicitly includes the anticipated loss of income from the company's Pharmaceuticals segment.
Risks and Contingencies
The filing includes standard forward-looking statement disclaimers, noting that projections are not guarantees and involve significant risks. Identified risk factors include:
- Economic conditions
- Competitive pressures
- Challenges associated with research and development
- Market acceptance of new products
- Regulatory approval
The company stated it does not undertake to update these forward-looking statements based on future developments.
Investor Verification Checklist
- Verify the specific financial impact and timeline for the divestiture or loss of the Pharmaceuticals segment.
- Review the company's most recent quarterly or annual reports to establish the baseline 2008 profitability figures referenced by management.
- Monitor subsequent filings for updates on the two-and-a-half to three-year recovery timeline, noting the company's disclaimer against updating forward-looking statements.